Health Cabinet Secretary Aden Duale has announced that all pharmacies, chemists, drug manufacturers, importers, distributors, wholesalers, and healthcare facilities that handle pharmaceutical products must complete fresh registration starting July 1, 2026.
He delivered the directive during the 46th Annual Pharmaceutical Society of Kenya Conference in Mombasa, describing it as part of reforms meant to tighten oversight across the sector.
Duale said every player in the pharmaceutical supply chain must register and maintain active compliance with three national digital platforms that the government plans to roll out beginning next month. He added that, from July 1, 2026, pharmacists, pharmaceutical technologists, pharmacies, chemists, manufacturers, importers, distributors, wholesalers, and healthcare facilities handling pharmaceutical products will be required to register, integrate with the platforms, and stay compliant.
The platforms include the National Track and Trace System (NTTS), Practice360, and Facility360. The government says they will improve monitoring, licensing, and regulation of pharmaceutical products and professionals.
According to the Health Ministry, the National Track and Trace System will provide end-to-end monitoring of pharmaceutical products, covering everything from importation and manufacturing to distribution, prescription, dispensing, and consumption.
Practice360 will act as the national licensing and professional management platform for pharmacists and pharmaceutical technologists, while Facility360 will oversee licensing.
“To strengthen pharmaceutical governance, combat counterfeit medicines, and ensure compliance with national health regulations, the Ministry of Health shall implement three national digital platforms across the pharmaceutical sector,” Duale said.
In addition to the registration requirement, the ministry says pharmaceutical manufacturers, importers, distributors, wholesalers, pharmacies, chemists, and healthcare facilities must also comply with GS1 Global Standards for product identification, serialization, authentication, and traceability.
The ministry says the institutions will also have to capture and report pharmaceutical products and transactions through the National Logistics Management Information System and the National Track and Trace System.
The directive further requires stakeholders to keep accurate electronic records covering pharmaceutical inventory, distribution, dispensing, and utilization data.
The Health Ministry added that the requirements will be implemented under the Digital Health Act, 2023; the Health Act; and relevant provisions of the Pharmacy and Poisons Act.
